Compounds > artenimol
Page last updated: 2024-08-26

artenimol and cgp-56697

artenimol has been researched along with cgp-56697 in 91 studies

Research

Studies (91)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (5.49)29.6817
2010's56 (61.54)24.3611
2020's30 (32.97)2.80

Authors

AuthorsStudies
Anstey, NM; Ebsworth, EP; Kenangalem, E; Laihad, F; Maristela, R; Price, RN; Ratcliff, A; Siswantoro, H; Tjitra, E; Wuwung, RM1
Kager, PA; Mens, PF; Omar, SA; Sawa, P; Schallig, HD; van Amsterdam, SM; Versteeg, I1
Arinaitwe, E; Dorsey, G; Greenhouse, B; Homsy, J; Kakuru, A; Kalamya, J; Kamya, MR; Rosenthal, PJ; Sandison, TG; Tappero, J; Vora, N; Wanzira, H1
Douglas, NM; Price, RN1
Arinaitwe, E; Bigira, V; Dorsey, G; Gasasira, A; Homsy, J; Kakuru, A; Kamya, MR; Katrak, S; Sandison, TG; Tappero, JW; Wanzira, H1
Dorsey, G; Greenhouse, B; Gupta, V; Hubbard, AE; Rosenthal, PJ1
Abdulla, S; Amuri, B; Fitoussi, S; Kabanywanyi, AM; Kaiser, G; Lefèvre, G; Nuortti, M; Pascoe, S; Reynolds, C; Séchaud, R; Ubben, D; Yeh, CM1
Ali, S; Lindegardh, N; Najmi, MH; Tarning, J1
Chaponda, M; D'Alessandro, U; Hachizovu, S; Mukwamataba, D; Mulenga, M; Nambozi, M; Ubben, D; Van Geertruyden, JP1
Ama, MV; Diatta, M; Djohan, V; Evi, JB; Faye, B; Faye, O; Kassi, RR; Koné, M; Kuete, T; Ndiaye, JL; Oga, SA; Same-Ekobo, A; Tine, R; Yavo, W1
Abdallah, A; Bashraheil, M; Borrmann, S; Fegan, G; Frühauf, H; Hanpithakpong, W; Juma, E; Lindegårdh, N; Lowe, B; Mackinnon, M; Marsh, K; Mosobo, M; Muriithi, S; Mwai, L; Nzila, A; Osier, F; Peshu, J; Peshu, N; Pfeil, J; Rippert, A; Sasi, P; Schaub, B; Tsofa, B1
Bashraheil, M; Bassat, Q; González, R; Kipkeu, C; Lefèvre, G; Lyimo, J; Machevo, S; Maiga, H; Mårtensson, A; Menéndez, C; Nahum, A; Nwaiwu, O; Ogutu, B; Ouma, P; Ubben, D; Walter, V1
D'Alessandro, U; Donegan, S; Tudur Smith, C; Williamson, P1
Aweeka, FT; Dorsey, G; Havlir, D; Huang, L; Lizak, P; Marzan, F; Parikh, S; Rosenthal, PJ1
Charman, SA; Gamo-Benito, J; Humberstone, A; Jamsen, KM; McCaw, J; Moehrle, J; Price, RN; Simpson, JA; Smith, K; Zaloumis, S1
Ariey, F; Beck, HP; Csajka, C; Decosterd, LA; Duong, S; Genton, B; Guidi, M; Kabanywanyi, AM; Olliaro, P; Staehli Hodel, EM1
Arinaitwe, E; Bigira, V; Dorsey, G; Homsy, J; Jagannathan, P; Kakuru, A; Kamya, MR; Muhindo, M; Osilo, E; Tappero, JW; Wanzira, H1
Price, RN1
Baidjoe, AY; Beshir, KB; Bousema, T; Drakeley, CJ; Hallett, RL; Hermsen, CC; Kavishe, RA; Manjurano, A; Mweresa, CK; Okell, L; Omar, SA; Sauerwein, RW; Sawa, P; Schallig, HD; Shekalaghe, SA; Sutherland, CJ; Yussuf, RU1
Agarwal, A; Desai, M; Kachur, SP; Kariuki, S; McMorrow, M; Odero, C; Onyango, P; Otieno, K; Slutsker, L; Williamson, J1
Beshir, KB; Bousema, T; Chilongola, J; Drakeley, CJ; Hallett, RL; Kaur, H; Mweresa, CK; Ndaro, A; Okell, L; Omar, SA; Sauerwein, RW; Sawa, P; Schallig, HD; Shekalaghe, SA; Sutherland, CJ1
Bellettre, X; Bouchaud, O; Michel, JF; Pull, L; Siriez, JY1
Gogtay, N; Kannan, S; Olliaro, PL; Sinclair, D; Thatte, UM1
Donegan, S; Gathu, M; Olliaro, PL; Sinclair, D; Zani, B1
Arinaitwe, E; Dorsey, G; Jagannathan, P; Kaharuza, F; Kakuru, A; Kamya, MR; Muhindo, MK; Orukan, F; Osilo, E; Talisuna, A; Tappero, JW1
Akhwale, W; Eyase, F; Johnson, JD; Juma, E; Koskei, N; Obonyo, C; Ogutu, BR; Omollo, R; Omondi, EK; Ongecha, JM; Onyango, KO; Otieno, GA; Otieno, L; Perkins, DJ1
Hastings, IM; Hayes, DJ; Hodel, EM; Kay, K; Terlouw, DJ1
Borrmann, S; Pfeil, J; Tozan, Y1
Arinaitwe, E; Bigira, V; Conrad, M; Dorsey, G; Kakuru, A; Kamya, MR; Muhindo, MK; Rosenthal, PJ; Tappero, JW; Wanzira, H1
Cheah, PY; Day, NP; Dondorp, AM; Fanello, CI; Nosten, F; Onyamboko, MA; Tarning, J; Tshefu, KA; White, NJ; Wongsaen, K1
Mori, AT; Ngalesoni, F; Norheim, OF; Robberstad, B1
Dimbu, PR; Fortes, F; Goldman, I; Lucchi, N; Macaia, AP; MacArthur, JR; Morton, L; Plucinski, MM; Stennies, G; Talundzic, E; Udhayakumar, V1
Baraka, V; D'Alessandro, U; Delgado-Ratto, C; Erhart, A; Fitzhenry, R; Mbonye, MK; Rosanas-Urgell, A; Tinto, H; Valea, I; Van Geertruyden, JP; Van Overmeir, C1
Claeys, Y; D'Alessandro, U; De Crop, M; Halidou, T; Kalanda, G; Menten, J; Mulenga, M; Mutabingwa, T; Mwakazanga, D; Mwapasa, V; Nambozi, M; Phiri, LK; Ravinetto, R; Schurmans, C; Tagbor, H; Thriemer, K; Traore, M; Valea, I; Van Geertruyden, JP1
Ewing, VL; Kapinda, A; Lalloo, DG; Pace, C; Richards, E; Terlouw, DJ; Tolhurst, R1
Ali, IM; Chedjou, JP; Ekollo, AM; Evehe, MS; Froeschl, G; Heumann, C; Mansmann, U; Mbacham, WF; Moyeh, MN; Ndikum, VN; Ngongang, EO; Nji, AM; Ogundahunsi, O1
Alao, MJ; Cousin, M; Duparc, S; Hamed, K; Jain, JP; Lefèvre, G; Lingani, M; Meremikwu, M; Ogutu, B; Ouedraogo, A; Tinto, H; Tiono, AB; Tshefu, A1
Eckhoff, P; Gerardin, J; Wenger, EA1
Hastings, IM; Kay, K1
Bassat, Q; Borrmann, S; Mulenga, M; Pfeil, J; Talisuna, A; Tozan, Y1
Mori, AT; Norheim, OF; Robberstad, B1
Baird, JK; Boni, MF; Dondorp, AM; Farrar, J; Lam, HM; Nguyen, TD; Olliaro, P; Thwaites, GE; White, NJ1
Afonso, M; Dimbu, PR; Ferreira, CM; Fortes, F; Garrett, DO; Halsey, ES; He, Y; Kelley, JS; Kiniffo, R; Macaia, AP; Mbounga, E; Patel, DS; Plucinski, MM; Quivinja, J; Ringwald, P; Samutondo, C; Talundzic, E; Udhayakumar, V1
Buyze, J; D'Alessandro, U; Hachizovu, S; Kabuya, JB; Kasongo, W; Mulenga, J; Mulenga, M; Mwakazanga, D; Nambozi, M; Van Geertruyden, JP1
Bridges, DJ; Chalwe, V; Hamainza, B; Larsen, DA; Miller, JM; Moonga, H; Nyangu, J; Silumbe, K; Steketee, R1
Andrade, BN; Davlantes, E; Dimbu, PR; Dos Santos Souza, S; Félix, J; Ferreira, CM; Florinda Joao, M; Fortes, F; Halsey, ES; Martins, JF; Mbounga, E; Owens, C; Plucinski, MM; Pode, D; Sanhangala, E; Talundzic, E; Udhayakumar, V; Wiesner, L1
Banda, RL; Fulakeza, JRM; Hodel, EM; Lipenga, TR; Nkhoma, SC; Terlouw, DJ1
Abdulkadir, M; Aderoyeje, T; Agomo, C; Akano, K; Ambe, J; Ebenebe, JC; Emechebe, G; Ezeigwe, NM; Finomo, F; Folarin, OA; Happi, C; Jiya, N; Mokuolu, O; Ntadom, G; Oguche, S; Oyibo, W; Sowunmi, A; Useh, F; Wammanda, R1
Gesase, S; Ishengoma, DS; Kavishe, RA; Lemnge, MM; Mandara, CI; Mandike, R; Mghamba, J; Mkude, S; Mmbuji, P; Mohamed, A; Ngadaya, E; Njau, R; Warsame, M1
Aol, G; Bigogo, GM; Desai, M; Hill, J; Laserson, KF; Phillips-Howard, PA; Taegtmeyer, M; Ter Kuile, F; Young, N1
Dama, S; Dara, A; Djimde, AA; Djimde, M; Doumbo, OK; Guindo, CO; Niangaly, H; Sagara, I; Zeguime, A1
Hetzel, MW; Karl, S; Kattenberg, JH; Kiniboro, B; Laman, M; Makita, L; Mueller, I; Oswyn, G; Pulford, J; Rare, L; Robinson, L; Siba, PM; Tavul, L; Teliki, A; Walsh, D1
Chacky, F; Ishengoma, DS; Kabanywanyi, AM; Kakolwa, MA; Kamugisha, E; Kataraihya, JB; Lemnge, MM; Mahende, MK; Mandara, CI; Mandike, R; Menard, D; Mkude, S; Ngasala, B; Njau, R; Premji, Z; Warsame, M1
Bosco, A; Conrad, M; Kalyesubula, S; Kibuuka, A; Kigozi, R; Kyambadde, P; Mulebeke, R; Opigo, J; Rosenthal, PJ; Senzoga, J; Vinden, J; Wallender, E; Yeka, A1
Beavogui, AH; Borghini-Fuhrer, I; Djimdé, AA; Duparc, S; Felices, M; Funck-Brentano, C; Khan, Y; Ouedraogo, JB; Ouologuem, N; Sagara, I; Sirima, SB; Soulama, I; Voiriot, P1
Hakizimana, D; Kabera, M; Kayobotsi, C; Mbituyumuremyi, A; Munyaneza, T; Murindahabi, M; Musanabaganwa, C; Muvunyi, CM; Nisingizwe, MP; Ntagwabira, E; Penkunas, MJ; Umulisa, N; Uwimana, A; Uyizeye, D; Warsame, M1
Abdulrahman, A; Amran, JGH; Arale, AM; Gomey, AH; Hassan, AH; Hassan, AM; Jibril, AM; Khim, N; Mohamed, MS; Nur, ZS; Osman, SM; Ringwald, P; Warsame, M; Witkowski, B; Yusuf, FE1
Abreha, T; Adam, I; Anstey, NM; Assefa, A; Awab, GR; Baird, JK; Barber, BE; Chu, CS; Commons, RJ; Dahal, P; Daher, A; Davis, TME; Dondorp, AM; Grigg, MJ; Guerin, PJ; Hien, TT; Humphreys, GS; Hwang, J; Karunajeewa, H; Laman, M; Lidia, K; Moore, BR; Mueller, I; Nosten, F; Pasaribu, AP; Pereira, DB; Phyo, AP; Poespoprodjo, JR; Price, RN; Sibley, CH; Simpson, JA; Stepniewska, K; Sutanto, I; Thriemer, K; Thwaites, G; White, NJ; William, T; Woodrow, CJ1
Burugu, M; Chege, W; Kimani, F; Matoke-Muhia, D; Muregi, F; Musyoka, KB; Nambati, EA; Omondi, P; Otinga, M; Thiongo, K; Too, E1
Badjanga, BB; Day, NPJ; Fanello, C; Hoglund, RM; Jackson, NV; Kabedi, C; Kayembe, D; Lee, SJ; McGready, R; Nosten, F; Onyamboko, MA; Tarning, J; Turner, GDH; White, NJ1
Aye, KH; Bustos, MD; Han, KT; Han, ZY; Lin, K; Markwalter, CF; Moe, M; Myint, MK; Nyunt, MM; Plowe, CV; Rahman, MM; Ringwald, P; Simmons, R; Thi, A1
Aweeka, F; Huang, L; Hughes, E; Kajubi, R; Mwebaza, N; Mwima, MW; Nguyen, V; Nyunt, MM; Orukan, F; Parikh, S1
Amaratunga, C; Amato, R; Anvikar, AR; Ashley, E; Baidya, S; Behera, PK; Callery, JJ; Chau, NH; Cheah, PY; Chotivanich, K; Chutasmit, K; Day, NPJ; Dhorda, M; Dondorp, AM; Fairhurst, RM; Faiz, A; Fanello, C; Gantait, K; Ghosh, T; Gonçalves, S; Grobusch, MP; Hanboonkunupakarn, B; Heaton, J; Hien, TT; Hlaing, TM; Hoa, NT; Hoglund, RM; Huy, R; Imwong, M; Jacob, CG; Jittamala, P; Kaewmok, W; Kwiatkowski, DP; Lek, D; Lin, K; Mao, S; Maude, RJ; Mayxay, M; Miotto, O; Mohanty, AK; Mukaka, M; Newton, PN; Onyamboko, M; Oun, S; Pearson, RD; Peto, TJ; Pukrittayakamee, S; Pyae Phyo, A; Runcharern, R; Saelow, C; Satpathi, P; Satpathi, S; Smithuis, F; Sovann, Y; Sreng, S; Suon, S; Tarning, J; Thanh, NV; Thant, M; Thuy-Nhien, NT; Tripura, A; Tripura, R; Ul Islam, A; Valecha, N; van der Pluijm, RW; van Vugt, M; von Seidlein, L; Waithira, N; White, NJ; Winterberg, M; Woodrow, CJ; Yen, S1
Badiane, AS; Dème, AB; Diallo, I; Diallo, MA; Dieye, B; Diongue, K; Gomis, JF; Ndiaye, D; Ndiaye, M; Ndiaye, YD; Seck, MC; Sow, D; Sy, M; Sy, SA; Yade, MS1
Alemayehu, BH; Amaratunga, C; Anvikar, AR; Ashley, EA; Asih, PBS; Carrara, VI; Commons, RJ; D'Alessandro, U; Davis, TME; Dondorp, AM; Douglas, NM; Edstein, MD; Fairhurst, RM; Ferreira, MU; Guerin, PJ; Hossain, MS; Hwang, J; Janssens, B; Karunajeewa, H; Kiechel, JR; Ladeia-Andrade, S; Laman, M; Lon, C; Mayxay, M; McGready, R; Moore, BR; Mueller, I; Newton, PN; Noedl, H; Nosten, F; Phyo, AP; Poespoprodjo, JR; Price, RN; Saunders, DL; Simpson, JA; Smithuis, F; Spring, MD; Stepniewska, K; Suon, S; Suputtamongkol, Y; Syafruddin, D; Thriemer, K; Thuy-Nhien, NT; Tran, HT; Valecha, N; Van Herp, M; Van Vugt, M; White, NJ1
Bélard, S; Kurth, F; Ramharter, M1
Badolo, O; Compaore, CS; Dao, B; Gansané, A; Kangoye, D; Kinda, R; Ménard, D; Moriarty, LF; Ouedraogo, E; Sondo, P; Soulama, E; Tapsoba, M; Tarama, C; Tchwenko, S; Tinto, H; Valea, I; Yerbanga, I1
Deng, C; Liang, Y; Lu, C; Song, J; Tan, B; Wang, Q; Wu, W; Xu, Q; Zhang, H; Zhou, C1
Hughes, E; Jagannathan, P; Mohamed Ali, A; Savic, RM; Wallender, E1
Assefa, DG; Bekele, D; Getachew, E; Joseph, M; Manyazewal, T; Tesfahunei, HA; Zeleke, ED1
Bancone, G; Carrara, VI; Chu, C; Duanguppama, J; Gilder, ME; Haohankhunnatham, W; Imwong, M; Konghahong, K; Lee, SJ; McGready, R; Min, AM; Nosten, F; Paw, MK; Phyo, AP; Pimanpanarak, M; Proux, S; Saito, M; Singhasivanon, P; Tun, NW; Turner, C; Viladpai-Nguen, J; White, NJ1
Baltzell, K; Benjamin-Chung, J; Bhangu, K; Dlamini, B; Dlamini, N; Dufour, MK; Gosling, R; Greenhouse, B; Helb, D; Hsiang, MS; Kalungero, M; Kunene, S; Malambe, C; Maphalala, G; Mngadi, N; Nhlabathi, N; Ntshalintshali, N; Pindolia, D; Prach, LM; Tesfa, G; Vilakati, S; Whittemore, B1
Assefa, DG; Makonnen, E; Yismaw, G2
Chowell-Puente, G; Halsey, ES; Jones, S; Kahunu, GM; Kaputu, AK; Likwela, JL; Lucchi, N; Mavoko, HM; Moriarty, LF; Mulopo, PM; Muyembe Tamfum, JJ; Ngoyi, DM; Niang, M; Nkoli, PM; Ntamabyaliro, NY; Plucinski, MM; Rika, JM; Sadou, A; Schmedes, SE; Sompwe, EM; Subramaniam, G; Svigel, SS1
Asua, V; Belay, K; Bosco, A; Bwanika, JB; Ebong, C; Gonahasa, S; Gudoi, S; Halsey, ES; Kamya, MR; Kapisi, J; Kigozi, R; Kyabayinze, D; Lucchi, NW; Moriarty, LF; Mpimbaza, A; Namuganga, JF; Niang, M; Nsobya, SL; Opigo, J; Rubahika, D; Rutazana, D; Sebikaari, G; Souza, SSS; Sserwanga, A; Tibenderana, J; Yeka, A1
Assefa, DG; Bate, AF; Bekele, E; Makonnen, E; Mebratu, A; Mengistu, N; Molla, W; Sefa, A; Yesmaw, G; Zeleke, ED1
Baraka, V; Kamugisha, E; Kapesa, A; Kidenya, B; Konje, E; Marwa, K; Mukonzo, J; Swedberg, G1
Grundmann, O; Hernandez Maldonado, J1
Buff, AM; Chebore, W; Desai, M; Kariuki, S; Otieno, K; Owidhi, M; Samuels, AM; Westercamp, N1
Abera, A; Alemayehu, BH; Anand, A; Assefa, A; Bekele, W; Dilu, D; Etana, K; Ezema, B; Girma, S; Haile, M; Hwang, J; Minta, AA; Mohammed, H; Moriarty, LF; Murphy, M; Sime, H; Solomon, H; Svigel, SS; Tadesse, M; Tadesse, Y; Tasew, G; Teka, H; Woyessa, A; Zhou, Z1
Abongo, G; Basara, BB; Baseke, J; Bongo, GS; Day, NJP; Dhorda, M; Dondorp, AM; Fanello, C; Kayembe, DK; Maitland, K; Muhindo, R; Mukaka, M; Namayanja, C; Ndjowo, PO; Okalebo, CB; Olupot-Olupot, P; Onyamboko, MA; Onyas, P; Peerawaranun, P; Tarning, J; Taya, C; Taylor, WR; Titin, H; Uyoga, S; Waithira, N; Weere, W; Williams, TN1
Adjei, GO; Ahorhorlu, SY; Alifrangis, M; Duah-Quashie, NO; Dzudzor, B; Hansson, H; Jensen, RW; Kudzi, W; Nartey, ET; Quashie, NB; Wang, CW; Zoiku, F1
Akala, HM; Amwoma, JG; Andagalu, BM; Chemwor, GC; Cheruiyot, AC; Egbo, TE; Garges, EC; Juma, DW; Juma, JA; Kamau, E; Mwakio, EW; Ogutu, BR; Okoth, RO; Onyango, IA; Opot, BH; Roth, AL; Wakoli, DM; Watson, OJ; Yedah, RA1
Aina, O; Awolola, ST; Babatunde, S; David, AN; Ekama, SO; Happi, CT; Ijezie, SN; Mohammed, AB; Mokuolu, O; Musa, AZ; Ogbulafor, N; Oguche, S; Okafor, H; Olukosi, AY; Ozor, L; Salako, BL; Uhomoibhi, PE; Wammanda, R1
Chepngetich, J; Gachie, B; Gathirwa, J; Kiboi, D; Kimani, F; Magoma, G; Muriithi, B; Mwitari, P; Onchieku, N; Thiong'o, K1
D'Alessandro, U; Dabira, ED; Diakite, H; Djimde, M; Dorlo, TP; Erhart, A; González, R; Kabore, B; Kayentao, K; Keita, M; Macuacua, S; Menendez, C; Mens, P; Muhindo, HM; Piqueras, M; Sagara, I; Schallig, H; Sevene, E; Tinto, H; Traore, M; Tshiongo, JK; Vala, A1
Arama, C; Beavogui, AH; Dicko, A; Djimde, A; Djimde, M; Fofana, B; Kayentao, K; Mens, PF; Ouedraogo, JB; Sagara, I; Schallig, HD; Sirima, SB; Tshiongo, JK1
Bamisaiye, A; Basara, BB; Baseke, J; Day, NPJ; Fanello, C; Kayembe, DK; Maitland, K; Muhindo, R; Mukaka, M; Namayanja, C; Ndjowo, PO; Okalebo, CB; Olupot-Olupot, P; Onyamboko, MA; Onyas, P; Taya, C; Taylor, WRJ; Titin, H; Uyoga, S; Were, W; Williams, TN1

Reviews

12 review(s) available for artenimol and cgp-56697

ArticleYear
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
    The Cochrane database of systematic reviews, 2013, Oct-25, Issue:10

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria, Vivax; Parasitemia; Primaquine; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Secondary Prevention; Sulfadoxine

2013
Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria.
    The Cochrane database of systematic reviews, 2014, Jan-20, Issue:1

    Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Quinolines; Randomized Controlled Trials as Topic

2014
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis.
    PLoS medicine, 2019, Volume: 16, Issue:10

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Humans; Malaria, Vivax; Plasmodium vivax; Primaquine; Quinolines; Recurrence; Risk; Treatment Outcome

2019
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network.
    PLoS medicine, 2020, Volume: 17, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Parasitemia; Plasmodium vivax; Young Adult

2020
Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children.
    The Cochrane database of systematic reviews, 2020, 12-08, Volume: 12

    Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Bias; Child; Child, Preschool; Confidence Intervals; Drug Combinations; Humans; Infant; Malaria, Falciparum; Quinolines; Randomized Controlled Trials as Topic; Suspensions; Tablets; Treatment Failure; Vomiting

2020
Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations.
    Clinical pharmacology and therapeutics, 2021, Volume: 110, Issue:4

    Topics: Amodiaquine; Anti-HIV Agents; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Global Health; HIV Infections; Humans; Malaria; Malnutrition; Mefloquine; Models, Biological; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Vulnerable Populations

2021
Efficacy and safety of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ugandan children: a systematic review and meta-analysis of randomized control trials.
    Malaria journal, 2021, Apr-01, Volume: 20, Issue:1

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Malaria, Falciparum; Quinolines; Randomized Controlled Trials as Topic; Uganda

2021
Efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria among children in Africa: a systematic review and meta-analysis of randomized control trials.
    Malaria journal, 2021, Aug-12, Volume: 20, Issue:1

    Topics: Adolescent; Africa; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Malaria, Falciparum; Polymerase Chain Reaction; Quality Control; Quinolines; Randomized Controlled Trials as Topic; Regression Analysis; Sensitivity and Specificity; Time Factors

2021
Comparative effect of dihydroartemisinin-piperaquine and artemether-lumefantrine on gametocyte clearance and haemoglobin recovery in children with uncomplicated Plasmodium falciparum malaria in Africa: a systematic review and meta-analysis of randomized c
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 113

    Topics: Africa; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Fluorenes; Hemoglobins; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Randomized Controlled Trials as Topic

2021
Safety of dihydroartemisinin-piperaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria among children in Africa: a systematic review and meta-analysis of randomized control trials.
    Malaria journal, 2022, Jan-04, Volume: 21, Issue:1

    Topics: Adolescent; Africa; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Randomized Controlled Trials as Topic

2022
Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
    PloS one, 2022, Volume: 17, Issue:3

    Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines

2022
Drug-Drug Interactions of Artemisinin-Based Combination Therapies in Malaria Treatment: A Narrative Review of the Literature.
    Journal of clinical pharmacology, 2022, Volume: 62, Issue:10

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum

2022

Trials

44 trial(s) available for artenimol and cgp-56697

ArticleYear
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Lancet (London, England), 2007, Mar-03, Volume: 369, Issue:9563

    Topics: Adolescent; Adult; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Diarrhea; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Indonesia; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Prospective Studies; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome; Urticaria; Vomiting

2007
A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya.
    Malaria journal, 2008, Nov-18, Volume: 7

    Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Blood; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kenya; Malaria, Falciparum; Male; Microscopy; Parasitemia; Plasmodium falciparum; Quinolines; Self-Sustained Sequence Replication; Treatment Outcome

2008
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Dec-01, Volume: 49, Issue:11

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Quinolines; Treatment Outcome; Uganda

2009
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children.
    Malaria journal, 2009, Nov-30, Volume: 8

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; HIV Infections; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Quinolines; Risk Factors; Treatment Outcome; Uganda

2009
Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects.
    Malaria journal, 2010, Sep-03, Volume: 9

    Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Biological Availability; Child; Cross-Over Studies; Drug Combinations; Ethanolamines; Female; Flavoring Agents; Fluorenes; Human Experimentation; Humans; Male; Tablets; Tanzania

2010
Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.
    Malaria journal, 2011, Feb-28, Volume: 10

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Treatment Outcome; Zambia

2011
Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.
    Malaria journal, 2011, Jul-20, Volume: 10

    Topics: Adolescent; Adult; Aged; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Cameroon; Child; Child, Preschool; Cote d'Ivoire; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Middle Aged; Quinolines; Senegal; Treatment Outcome; Young Adult

2011
A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial.
    PLoS medicine, 2011, Volume: 8, Issue:11

    Topics: Adult; Africa South of the Sahara; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male

2011
Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast.
    PloS one, 2011, Volume: 6, Issue:11

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kenya; Malaria, Falciparum; Male; Plasmodium falciparum; Quinolines; Survival Rate

2011
Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight ranges.
    Malaria journal, 2011, Dec-16, Volume: 10

    Topics: Age Factors; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Body Weight; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Time Factors; Treatment Outcome

2011
Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers.
    Journal of acquired immune deficiency syndromes (1999), 2012, Nov-01, Volume: 61, Issue:3

    Topics: Adult; Alkynes; Anti-HIV Agents; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Benzoxazines; Cross-Over Studies; Cyclopropanes; Drug Combinations; Drug Interactions; Ethanolamines; Female; Fluorenes; Humans; Male; Middle Aged; Young Adult

2012
The effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children.
    The American journal of tropical medicine and hygiene, 2013, Volume: 88, Issue:4

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; HIV Infections; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Multivariate Analysis; Parasitemia; Plasmodium falciparum; Post-Exposure Prophylaxis; Prevalence; Proportional Hazards Models; Quinolines; Risk Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Trophozoites; Uganda

2013
Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial.
    The Journal of infectious diseases, 2013, Jun-01, Volume: 207, Issue:11

    Topics: Animals; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Culicidae; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kenya; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Secondary Prevention; Time Factors; Treatment Outcome

2013
A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya.
    Malaria journal, 2013, Jul-19, Volume: 12

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Kenya; Malaria, Falciparum; Male; Quinolines; Treatment Outcome

2013
Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence.
    The Journal of infectious diseases, 2013, Dec-15, Volume: 208, Issue:12

    Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chi-Square Distribution; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Infant; Kenya; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Recurrence

2013
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria.
    Malaria journal, 2014, Jan-28, Volume: 13

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Kinetics; Longitudinal Studies; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Quinolines; Risk Factors; Uganda

2014
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study.
    Malaria journal, 2014, Jan-28, Volume: 13

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Kenya; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Tablets

2014
Longitudinal outcomes in a cohort of Ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Aug-15, Volume: 59, Issue:4

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Cohort Studies; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; HIV Infections; Hospitalization; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Quinolines; Recurrence; Time Factors; Treatment Outcome; Uganda

2014
Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9

    Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Democratic Republic of the Congo; Drug Combinations; Erythrocyte Count; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Quinolines; Treatment Outcome

2014
Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial.
    Reproductive health, 2015, Jan-15, Volume: 12

    Topics: Adult; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Birth Weight; Burkina Faso; Drug Combinations; Ethanolamines; Female; Fetal Development; Fluorenes; Follow-Up Studies; Ghana; Humans; Infant, Newborn; Malaria; Malawi; Mefloquine; Placentation; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Exposure Delayed Effects; Quinolines; Zambia

2015
Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study.
    Malaria journal, 2015, Jan-21, Volume: 14

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Drug Utilization; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria; Malawi; Male; Medication Adherence; Quinolines; Surveys and Questionnaires

2015
Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.
    Malaria journal, 2015, Jan-28, Volume: 14

    Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Cameroon; Child; Child, Preschool; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Quinolines; Treatment Outcome

2015
Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).
    Malaria journal, 2015, Apr-15, Volume: 14

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Treatment Outcome

2015
Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria.
    Malaria journal, 2017, 05-16, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria; Mefloquine; Pregnancy; Quinolines; Recurrence; Risk; Treatment Outcome; Young Adult; Zambia

2017
Community-led Responses for Elimination (CoRE): a study protocol for a community randomized controlled trial assessing the effectiveness of community-level, reactive focal drug administration for reducing Plasmodium falciparum infection prevalence and inc
    Trials, 2017, Nov-02, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Clinical Protocols; Community Health Services; Drug Administration Schedule; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Incidence; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Prevalence; Quinolines; Research Design; Risk Factors; Time Factors; Treatment Outcome; Young Adult; Zambia

2017
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    Lancet (London, England), 2018, 04-07, Volume: 391, Issue:10128

    Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Longitudinal Studies; Malaria; Male; Naphthyridines; Quinolines; Young Adult

2018
Comparison of Two Genotyping Methods for Distinguishing Recrudescence from Reinfection in Antimalarial Drug Efficacy/Effectiveness Trials.
    The American journal of tropical medicine and hygiene, 2018, Volume: 99, Issue:1

    Topics: Antigens, Protozoan; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Cluster Analysis; Drug Combinations; Female; Gene Expression; Genotype; Genotyping Techniques; Humans; Malaria, Falciparum; Malawi; Male; Merozoite Surface Protein 1; Merozoites; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinolines; Recurrence; Treatment Outcome

2018
High efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania.
    Malaria journal, 2018, Jul-11, Volume: 17, Issue:1

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Quinolines; Tanzania

2018
A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Malaria journal, 2018, Oct-05, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Mali; Middle Aged; Plasmodium falciparum; Quinolines; Young Adult

2018
Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
    Malaria journal, 2018, Oct-05, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Inhibitory Concentration 50; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Quinolines; Young Adult

2018
Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children.
    The Journal of infectious diseases, 2019, 03-15, Volume: 219, Issue:7

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Comparative Effectiveness Research; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Protozoan Proteins; Quinolines; Recurrence; Single-Blind Method; Uganda

2019
Efficacy of artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria among children in Rwanda: an open-label, randomized controlled trial.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2019, 06-01, Volume: 113, Issue:6

    Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Malaria; Male; Quinolines; Rwanda

2019
High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia.
    Malaria journal, 2019, Jul-11, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinolines; Somalia; Young Adult

2019
A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa.
    Antimicrobial agents and chemotherapy, 2020, 02-21, Volume: 64, Issue:3

    Topics: Adult; Africa; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Female; Humans; Malaria, Falciparum; Pregnancy; Young Adult

2020
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
    Lancet (London, England), 2020, 04-25, Volume: 395, Issue:10233

    Topics: Adolescent; Adult; Amodiaquine; Anthraquinones; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Treatment Outcome; Young Adult

2020
Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal.
    Scientific reports, 2020, 06-01, Volume: 10, Issue:1

    Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Microfilament Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Quinolines; Senegal; Sequence Analysis, DNA; Treatment Failure

2020
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
    BMC medicine, 2021, 06-10, Volume: 19, Issue:1

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Mefloquine; Myanmar; Pregnancy; Premature Birth; Quinolines; Thailand

2021
Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial.
    BMJ global health, 2021, Volume: 6, Issue:6

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Eswatini; Humans; Malaria; Mass Drug Administration; Quinolines

2021
Therapeutic Efficacy of Artemisinin-Based Combination Therapies in Democratic Republic of the Congo and Investigation of Molecular Markers of Antimalarial Resistance.
    The American journal of tropical medicine and hygiene, 2021, 09-07, Volume: 105, Issue:4

    Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Congo; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Piperazines; Plasmodium falciparum; Quinolines

2021
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia.
    Malaria journal, 2022, Dec-01, Volume: 21, Issue:1

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Ethiopia; Humans; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax

2022
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, n
    The Lancet. Infectious diseases, 2023, Volume: 23, Issue:4

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Democratic Republic of the Congo; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine; Uganda; World Health Organization

2023
Therapeutic response to artemisinin combination therapies among individuals with Plasmodium falciparum single infection vs mixed Plasmodium species infections: a retrospective posthoc analysis in Kisumu County, western Kenya.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2023, Volume: 132

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Humans; Kenya; Malaria; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Reinfection; Retrospective Studies

2023
Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of
    BMJ open, 2023, 10-09, Volume: 13, Issue:10

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Clinical Trials, Phase III as Topic; Drug Combinations; Female; Humans; Infant; Malaria; Malaria, Falciparum; Pregnancy; Pregnant Women; Randomized Controlled Trials as Topic; Sub-Saharan African People; Treatment Outcome

2023
Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo.
    BMC medicine, 2023, 10-20, Volume: 21, Issue:1

    Topics: alpha-Thalassemia; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Female; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine

2023

Other Studies

35 other study(ies) available for artenimol and cgp-56697

ArticleYear
Artemisinin combination therapy for malaria: beyond good efficacy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Dec-01, Volume: 49, Issue:11

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Quinolines; Treatment Outcome

2009
Gel versus capillary electrophoresis genotyping for categorizing treatment outcomes in two anti-malarial trials in Uganda.
    Malaria journal, 2010, Jan-15, Volume: 9

    Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Therapy, Combination; Electrophoresis, Agar Gel; Electrophoresis, Capillary; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Plasmodium; Quinolines; Randomized Controlled Trials as Topic; Treatment Outcome; Uganda

2010
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.
    Malaria journal, 2010, Oct-11, Volume: 9

    Topics: Administration, Oral; Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chromatography, Liquid; Drug Combinations; Ethanolamines; Fluorenes; Human Experimentation; Humans; Male; Middle Aged; Pakistan; Plasma; Tandem Mass Spectrometry; Time Factors

2010
Assessing the consistency assumption by exploring treatment by covariate interactions in mixed treatment comparison meta-analysis: individual patient-level covariates versus aggregate trial-level covariates.
    Statistics in medicine, 2012, Dec-20, Volume: 31, Issue:29

    Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Dapsone; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Meta-Analysis as Topic; Models, Statistical; Outcome Assessment, Health Care; Proguanil; Quinolines; Regression Analysis

2012
Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development.
    Malaria journal, 2012, Aug-30, Volume: 11

    Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Drug Combinations; Drug Discovery; Ethanolamines; Fluorenes; Host-Pathogen Interactions; Humans; Malaria, Falciparum; Mefloquine; Models, Statistical; Plasmodium falciparum; Quinolines

2012
Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Alleles; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Arylamine N-Acetyltransferase; Base Sequence; Cambodia; Cytochrome P-450 Enzyme System; Drug Combinations; Ethanolamines; Fluorenes; Gene Frequency; Humans; Isoenzymes; Malaria; Mefloquine; Pharmacogenetics; Polymorphism, Single Nucleotide; Quinolines; Sequence Analysis, DNA; Tanzania

2013
Potential of artemisinin-based combination therapies to block malaria transmission.
    The Journal of infectious diseases, 2013, Jun-01, Volume: 207, Issue:11

    Topics: Animals; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Quinolines

2013
[Treatment of severe and uncomplicated falciparum malaria in children in France].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2013, Volume: 20, Issue:11

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Child; Drug Combinations; Ethanolamines; Fluorenes; France; Humans; Malaria, Falciparum; Proguanil; Quinolines

2013
Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.
    Malaria journal, 2014, Apr-07, Volume: 13

    Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Computer Simulation; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria; Male; Quinolines; Treatment Outcome; Young Adult

2014
Dihydroartemisinin-piperaquine vs. artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children: a cost-effectiveness analysis.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Africa; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Cost-Benefit Analysis; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Infant, Newborn; Malaria; Markov Chains; Outcome Assessment, Health Care; Quinolines

2014
Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania.
    Malaria journal, 2014, Sep-15, Volume: 13

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Cost-Benefit Analysis; Drug Combinations; Ethanolamines; Female; Fluorenes; Health Care Costs; Hospitals, District; Humans; Infant; Infant, Newborn; Malaria; Male; Models, Statistical; Quinolines; Tanzania; Treatment Outcome

2014
Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1

    Topics: Angola; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Drug Resistance; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Quinolines; Treatment Failure

2015
In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1

    Topics: Antimanic Agents; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Genetic Variation; Humans; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Protozoan Proteins; Quinolines

2015
Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
    BMC infectious diseases, 2015, Mar-22, Volume: 15

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Models, Biological; Post-Exposure Prophylaxis; Prevalence; Primaquine; Quinolines; Young Adult; Zambia

2015
Measuring windows of selection for anti-malarial drug treatments.
    Malaria journal, 2015, Jul-31, Volume: 14

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Models, Biological; Plasmodium falciparum; Quinolines

2015
An Economic Evaluation of the Posttreatment Prophylactic Effect of Dihydroartemisinin-Piperaquine Versus Artemether-Lumefantrine for First-Line Treatment of Plasmodium falciparum Malaria Across Different Transmission Settings in Africa.
    The American journal of tropical medicine and hygiene, 2015, Volume: 93, Issue:5

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Markov Chains; Models, Biological; Models, Economic; Plasmodium falciparum; Quinolines; Recurrence

2015
Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania.
    PharmacoEconomics, 2016, Volume: 34, Issue:3

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Cost-Benefit Analysis; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Care Costs; Humans; Infant; Malaria; Markov Chains; Models, Economic; Quinolines; Tanzania

2016
Optimum population-level use of artemisinin combination therapies: a modelling study.
    The Lancet. Global health, 2015, Volume: 3, Issue:12

    Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Administration Schedule; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Models, Biological; Plasmodium falciparum; Quinolines; Treatment Failure

2015
Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015.
    Malaria journal, 2017, 02-02, Volume: 16, Issue:1

    Topics: Amodiaquine; Angola; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Quinolines; Recurrence; Treatment Failure

2017
Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
    Malaria journal, 2018, Apr-03, Volume: 17, Issue:1

    Topics: Adolescent; Amodiaquine; Angola; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Quinolines; Treatment Failure

2018
Efficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children Ten Years Following Adoption as First-Line Antimalarials.
    The American journal of tropical medicine and hygiene, 2018, Volume: 99, Issue:3

    Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Quinolines; Treatment Outcome

2018
Integrated point-of-care testing (POCT) of HIV, syphilis, malaria and anaemia in antenatal clinics in western Kenya: A longitudinal implementation study.
    PloS one, 2018, Volume: 13, Issue:7

    Topics: Adult; Anemia; Anti-Bacterial Agents; Anti-HIV Agents; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Dietary Supplements; Erythromycin; Female; Folic Acid; Guideline Adherence; Health Personnel; HIV Infections; Humans; Iron, Dietary; Kenya; Laboratory Proficiency Testing; Longitudinal Studies; Malaria; Penicillins; Point-of-Care Testing; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Prenatal Care; Quinine; Quinolines; Syphilis; Trimethoprim, Sulfamethoxazole Drug Combination

2018
Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania.
    Malaria journal, 2018, Oct-17, Volume: 17, Issue:1

    Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Prospective Studies; Quinolines; Tanzania

2018
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method.
    Scientific reports, 2019, 01-29, Volume: 9, Issue:1

    Topics: Adolescent; Amodiaquine; Antimalarials; Arrhythmias, Cardiac; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Heart Rate; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Male; Quinolines; Young Adult

2019
Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether-lumefantrine or dihydroartemisinin-piperaquine treatment.
    Malaria journal, 2019, Dec-04, Volume: 18, Issue:1

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Plasmodium falciparum; Prevalence; Quinolines

2019
Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine Retain High Efficacy for Treatment of Uncomplicated
    The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:3

    Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Female; Genotype; Humans; Malaria, Falciparum; Male; Middle Aged; Myanmar; Plasmodium falciparum; Quinolines; Young Adult

2020
Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.
    Journal of acquired immune deficiency syndromes (1999), 2020, 02-01, Volume: 83, Issue:2

    Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Pregnancy; Prospective Studies; Uganda; Young Adult

2020
Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017-2018.
    Malaria journal, 2021, Jan-19, Volume: 20, Issue:1

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child, Preschool; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Quinolines

2021
Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients.
    Revista da Sociedade Brasileira de Medicina Tropical, 2021, Volume: 54

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Electrocardiography; Humans; Malaria; Malaria, Falciparum; Quinolines

2021
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda.
    Malaria journal, 2021, Dec-24, Volume: 20, Issue:1

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Biomarkers; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Uganda

2021
Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017.
    Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Folic Acid Antagonists; Humans; Infant; Kenya; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines; Reinfection

2022
Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana.
    Malaria journal, 2023, Feb-19, Volume: 22, Issue:1

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Drug Tolerance; Ghana; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum

2023
Design, Implementation, and Coordination of Malaria Therapeutic Efficacy Studies in Nigeria in 2018.
    The American journal of tropical medicine and hygiene, 2023, 06-07, Volume: 108, Issue:6

    Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Nigeria

2023
Prevalence of mutations in the cysteine desulfurase IscS (Pfnfs1) gene in recurrent Plasmodium falciparum infections following artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) treatment in Matayos, Western Kenya.
    Malaria journal, 2023, May-19, Volume: 22, Issue:1

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Humans; Kenya; Lumefantrine; Malaria; Malaria, Falciparum; Mutation; Plasmodium falciparum; Prevalence; Quinolines; Reinfection

2023
Variation in neutrophil levels and artemisinin-based combination therapy efficacy in West-Africa.
    Journal of infection in developing countries, 2023, 09-30, Volume: 17, Issue:9

    Topics: Africa; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Neutropenia; Neutrophils; Parasitemia; Plasmodium falciparum; Prospective Studies

2023